BVXP.LSE Bioventix

Healthcare Biotechnology London Exchange
20.50 GBX
Close of Nov 3, 2026
1,251 2,171
Market cap
GBX 107M
P/E
14.2x
P/B
9.38x
ROE
66.7%
Dividend yield
7.32%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is BVXP.LSE undervalued?

Graham number
Price20.50
Graham value8.41
Premium143.6%

BVXP.LSE trades 143.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bioventix fundamental analysis

No fundamental analysis for Bioventix yet.

Bioventix stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The c…

Full company profile